# Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers

> **NCT00520910** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 10 (actual)

## Conditions studied

- Aging
- Skin Abnormalities

## Interventions

- **DRUG:** Polypodium leucotomos

## Key facts

- **NCT ID:** NCT00520910
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520910, "Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00520910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*